RespireRx Pharmaceuticals Inc (fka RSPI)

[davidal66]

Yes, with money, lost of it because they dont' have the moxie to think with a single iota of creativity to try to devise a study to look for biological activity in ADHD in a quicker manner or more efficient manner than the last ADHD study. That would require a different management team. So they need to replicate the previous ADHD trial which would require money they don't possess. Funding first, then a long, drawn out, ADHD trial which will take triple the time they estimate it would with months of data analysis and results in two and a half years with the stock price at 5 cents a share by then.